We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Training Documentation: What Does the FDA Require?

Training Documentation: What Does the FDA Require?

November 26, 2014

Few things are more talked about in pharmaceutical manufacturing training than documentation and recordkeeping. Debates abound. Some issues training managers are grappling with include the following:

  • What are the FDA’s documentation requirements? 
  • Does the organization need an electronic documentation system?
  • Is validation of the electronic documentation system required?
  • If validation is required, how is it done?

FDA does not specify training documentation requirements in its regulations, but investigators have made clear the importance of recordkeeping by the way they conduct inspections.

According to Phil Pontikos, Consumer Safety Officer with the FDA’s Columbus, Ohio, office, investigators evaluate employee competency through observation and interview rather than just document review.

But if investigators encounter areas of concern, they may turn to training documentation to "back into" an audit of a company's training program. This typically happens in one of three ways:

  1. Investigators ask to see an SOP and observe an employee perform the procedure. Depending on the employee's per­formance, they may ask to review the documents or records of the observed employee's training.
  2. Through investigation of production records, investigators spot deviations or out-of-specification issues. This in turn may lead to an examination of an operator's work and qualifications for the job. The investigators may ask how or what additional training was conducted and request the records that prove training was provided.
  3. Investigators identify processes or work practices that appear to be performed incorrectly during a rou­tine tour of a manufacturing facility. They may ask to see the training materials or training records associated with individuals working in the area.

Many training managers have noted that if the training de­partment can produce documentation quickly and in an organized fashion, FDA investigators are more likely to view the overall training effort as effective. At the same time, when solid training documentation cannot be produced quickly, a more in-depth review of the training system may occur.

Electronic Documentation Systems

Three methods are commonly used for train­ing documentation/recordkeeping in the pharmaceuti­cal manufacturing industry: paper systems, electronic systems with paper backup, and stand-alone electronic systems.

Some pharmaceutical companies use a paper-based doc­umentation system, but most companies use some type of electronic system, with or without paper backup. These electronic systems, also known as Learning Management Systems (LMS), range from elaborate commercial programs to “home grown” databases created in Microsoft Access. Paper backup typically includes at least sign-in sheets and sometimes evaluation instruments.

An LMS is essentially a database made up of multiple tables to store discrete units of information. These might include employee information, course information, eval­uation data, and training programs or materials. These tables can be merged and queried to produce specific reports. Report capabilities allow users to compare, analyze, question and project training needs.

Validating Electronic Documentation Systems

Pharmaceutical manufacturing training managers will debate about whether electronic training documentation systems need to be validated. To date, the FDA has not consistently required them to be validated, but manufacturers should do so to ensure the reliability of their performance.

Validation protocols should include repetitive testing to achieve a high degree of confidence that the results will be replicable. Systems should be validated under normal conditions as well as anticipated upset conditions. Finally, backup and recovery procedures must be developed and validated.

Once a system is validated and put into use, change control is necessary to maintain the validated state. All changes must be reviewed and approved prior to imple­mentation. It is also a good idea to perform periodic reviews of the computer system. This involves a review of all changes over time as well as any problems that have occurred with the system.

Next week, we’ll look at the process of selecting, evaluating and implementing an electronic training documentation system.

Contact Information:
Dave Gallup
GMPTraining.com, Inc.
18585 Coastal Highway
Unit 10, #149
Rehoboth, DE 19971
215-870-5665
dagallup@gmptraining.com
www.gmptraining.com

Upcoming Events

  • 04Apr

    Optimizing Quality Control Operations with Unified Quality

  • 20Apr

    Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • NVIDIA and Medtronic to Develop Artificial Intelligence Solutions

  • FDA Approves Evkeeza for Kids With Ultra-Rare Cholesterol Disorder

  • GrayMatters Health’s Digital Therapy Device for PTSD Cleared

  • Dupixent Shows Positive Results in COPD Study

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing